Christina Rossi

Insider Reports History

Entity
Individual
Location
45 Sidney Street, Blueprint Medicines Corporation, Cambridge, MA
Signature
/s/ Melissa Masse
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christina Rossi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Blueprint Medicines Corp CHIEF OPERATING OFFICER Common Stock 73.9K $8.22M $111.20 Jul 1, 2024 Direct
Blueprint Medicines Corp CHIEF OPERATING OFFICER Stock Option (Right to Buy) 30K Mar 1, 2024 Direct
Xilio Therapeutics, Inc. Director Stock Option (right to buy) 25K Jun 14, 2024 Direct

Insider Reports Filed by Christina Rossi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BPMC Blueprint Medicines Corp Jul 1, 2024 1 $0 4 Jul 8, 2024 CHIEF OPERATING OFFICER
XLO Xilio Therapeutics, Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
BPMC Blueprint Medicines Corp Mar 7, 2024 1 -$550K 4 Mar 11, 2024 CHIEF OPERATING OFFICER
BPMC Blueprint Medicines Corp Mar 1, 2024 2 $0 4 Mar 6, 2024 CHIEF OPERATING OFFICER
XLO Xilio Therapeutics, Inc. Jun 12, 2023 1 $0 4 Jun 13, 2023 Director
BPMC Blueprint Medicines Corp Mar 6, 2023 2 -$140K 4 Mar 8, 2023 CHIEF OPERATING OFFICER
BPMC Blueprint Medicines Corp Mar 1, 2023 2 $0 4 Mar 3, 2023 CHIEF OPERATING OFFICER
BPMC Blueprint Medicines Corp Nov 3, 2022 1 -$24.1K 4 Nov 7, 2022 CHIEF OPERATING OFFICER
XLO Xilio Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
BPMC Blueprint Medicines Corp Mar 3, 2022 2 -$131K 4 Mar 8, 2022 CHIEF COMMERCIAL OFFICER
BPMC Blueprint Medicines Corp Mar 1, 2022 2 $0 4 Mar 3, 2022 CHIEF COMMERCIAL OFFICER
BPMC Blueprint Medicines Corp Nov 3, 2021 1 -$56.6K 4 Mar 23, 2022 CHIEF COMMERCIAL OFFICER
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 Director